Skip to main content
. 2016 Aug 8;103(2):132–138. doi: 10.1136/heartjnl-2016-309509

Figure 3.

Figure 3

Risk of CV or coronary events following interruption of DAPT versus remaining on DAPT. CV, cardiovascular; DAPT, dual antiplatelet therapy.